Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Does physician continuity within a clinical trial increase retention and compliance among adolescent smokers?

Lewis AL, Baker N, Carpenter M, Klintworth E, Gray KM.

Adolesc Psychiatry (Hilversum). 2013 Apr 1;3(2). doi: 10.2174/2210676611303020011.

2.

Smoking cessation with teenagers: the relationship between impulsivity, emotional problems, program retention and effectiveness.

Wegmann L, B├╝hler A, Strunk M, Lang P, Nowak D.

Addict Behav. 2012 Apr;37(4):463-8. doi: 10.1016/j.addbeh.2011.12.008. Epub 2011 Dec 22.

PMID:
22273584
3.

A six-month crossover chemoprevention clinical trial of tea in smokers and non-smokers: methodological issues in a feasibility study.

Dash C, Chung FL, Rohan JA, Greenspan E, Christopher PD, Makambi K, Hara Y, Newkirk K, Davidson B, Adams-Campbell LL.

BMC Complement Altern Med. 2012 Jul 16;12:96. doi: 10.1186/1472-6882-12-96.

4.

Internet-based interventions for smoking cessation.

Civljak M, Sheikh A, Stead LF, Car J.

Cochrane Database Syst Rev. 2010 Sep 8;(9):CD007078. doi: 10.1002/14651858.CD007078.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;7:CD007078.

PMID:
20824856
5.

Incentives for preventing smoking in children and adolescents.

Johnston V, Liberato S, Thomas D.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD008645. doi: 10.1002/14651858.CD008645.pub2. Review.

PMID:
23076949
6.

Nicotine replacement therapy for smoking cessation.

Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD000146. doi: 10.1002/14651858.CD000146.pub4. Review.

PMID:
23152200
7.

The protocol for the Be Our Ally Beat Smoking (BOABS) study, a randomised controlled trial of an intensive smoking cessation intervention in a remote Aboriginal Australian health care setting.

Marley JV, Atkinson D, Nelson C, Kitaura T, Gray D, Metcalf S, Murray R, Maguire GP.

BMC Public Health. 2012 Mar 23;12:232. doi: 10.1186/1471-2458-12-232.

8.

Predictors of smoking cessation in adolescents.

Sargent JD, Mott LA, Stevens M.

Arch Pediatr Adolesc Med. 1998 Apr;152(4):388-93.

PMID:
9559717
9.

Overcoming barriers to recruitment and retention in adolescent smoking cessation.

Kealey KA, Ludman EJ, Mann SL, Marek PM, Phares MM, Riggs KR, Peterson AV Jr.

Nicotine Tob Res. 2007 Feb;9(2):257-70.

PMID:
17365757
10.

Participant- and study-related characteristics predicting treatment completion and study retention in an adolescent smoking cessation trial.

Kalkhuis-Beam S, Stevens SL, Baumritter A, Carlson EC, Pletcher JR, Rodriguez D, Audrain-McGovern J.

J Adolesc Health. 2011 Oct;49(4):371-8. doi: 10.1016/j.jadohealth.2011.01.012. Epub 2011 May 24.

PMID:
21939867
11.

Do total smoking bans affect the recruitment and retention of adolescents in inpatient substance abuse treatment programs? A 5-year medical chart review, 2001-2005.

Callaghan RC, Brewster JM, Johnson J, Taylor L, Beach G, Lentz T.

J Subst Abuse Treat. 2007 Oct;33(3):279-85. Epub 2007 Mar 21.

PMID:
17376637
12.

Comparative effectiveness of post-discharge interventions for hospitalized smokers: study protocol for a randomized controlled trial.

Japuntich SJ, Regan S, Viana J, Tymoszczuk J, Reyen M, Levy DE, Singer DE, Park ER, Chang Y, Rigotti NA.

Trials. 2012 Aug 1;13:124. doi: 10.1186/1745-6215-13-124.

13.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
14.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
15.

Lifetime characteristics of participants and non-participants in a smoking cessation trial: implications for external validity and public health impact.

Graham AL, Papandonatos GD, DePue JD, Pinto BM, Borrelli B, Neighbors CJ, Niaura R, Buka SL, Abrams DB.

Ann Behav Med. 2008 Jun;35(3):295-307. doi: 10.1007/s12160-008-9031-1. Epub 2008 Apr 15.

PMID:
18414962
16.

Interventions for recruiting smokers into cessation programmes.

Marcano Belisario JS, Bruggeling MN, Gunn LH, Brusamento S, Car J.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD009187. doi: 10.1002/14651858.CD009187.pub2. Review.

PMID:
23235672
17.

Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking.

Walker N, Howe C, Bullen C, McRobbie H, Glover M, Parag V, Williman J, Veale R, Nosa V, Barnes J.

BMC Public Health. 2011 Nov 21;11:880. doi: 10.1186/1471-2458-11-880.

18.

Treatment of adolescent smokers with the nicotine patch.

Hanson K, Allen S, Jensen S, Hatsukami D.

Nicotine Tob Res. 2003 Aug;5(4):515-26.

PMID:
12959789
19.

Results of a randomized controlled trial of intervention to implement smoking guidelines in Veterans Affairs medical centers: increased use of medications without cessation benefit.

Joseph AM, Arikian NJ, An LC, Nugent SM, Sloan RJ, Pieper CF; GIFT Research Group.

Med Care. 2004 Nov;42(11):1100-10.

PMID:
15586837
20.

Relapse prevention interventions for smoking cessation.

Hajek P, Stead LF, West R, Jarvis M, Lancaster T.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD003999. doi: 10.1002/14651858.CD003999.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;8:CD003999.

PMID:
19160228
Items per page

Supplemental Content

Write to the Help Desk